Eargo Link vs Resound Vivia 9 60S microRIE

The Eargo Link is a mid-priced OTC hearing aid released in 2024, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $799, it ranks #15 of 65 OTC hearing aids tested, placing it in the top 22% of the category. In our testing, the Eargo Link demonstrates notable strengths in music streaming, scoring 4.4/5—a strong result that sits 2.48 points above the category average. This makes it a standout choice for users who prioritize audio quality when streaming from their phone. Speech performance is solid, with speech in quiet measuring 3.2/5 (0.42 points above average) and speech in noise at 2.0/5 (0.54 points above average, though mixed in absolute terms). Feedback handling is excellent at 4.7/5. The main limitation is own-voice comfort, which scores 1.3/5—a low result that falls 1.21 points below the category average. Users sensitive to the sound of their own voice may find this challenging, particularly with the closed dome configuration used in the tuned fit. The Eargo Link supports both iPhone and Android streaming with hands-free capability and uses rechargeable batteries. It's best suited for those who value exceptional music streaming quality and solid speech clarity, and who can tolerate some own-voice occlusion. Competitors in this price range include higher-scoring options like the Yeasound RIC800 and Sony CRE-E10, though the Eargo Link's streaming performance remains a differentiator.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.